Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy

被引：0
|
作者：
Afzali, A. [1 ]
Armuzzi, A. [2 ]
Bouhnik, Y. [3 ,4 ]
Bressler, B. [5 ]
Hart, A. [6 ]
Rubin, D. [7 ]
Sans, M. [8 ]
Siegmund, B. [9 ]
Sninsky, D. [10 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Inflammatory Bowel Dis, Columbus, OH 43210 USA
[2] Fdn Policlin A Gemelli IRCCS Univ Cattolica, Gastroenterol, Rome, Italy
[3] INSERM, Paris, France
[4] Univ Paris, Gastroenterol, Paris, France
[5] Univ British Columbia, Gastroenterol, Vancouver, BC, Canada
[6] St Marks Hosp, Gastroenterol, London, England
[7] Univ Chicago, Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
[8] Ctr Med Teknon, Gastroenterol, Barcelona, Spain
[9] Charite Univ Med Berlin, Gastroenterol Infectiol & Rheumatol, Berlin, Germany
[10] Digest Dis Associates, Gastroenterol, Gainesville, FL USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P393
引用
下载
收藏
页码：S366 / S367
页数：2
相关论文
共 50 条
  • [41] Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
    Roy, Supriya
    Dhaneshwar, Suneela
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (14) : 2078 - 2100
  • [42] Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease:Current perspectives
    Supriya Roy
    Suneela Dhaneshwar
    World Journal of Gastroenterology, 2023, (14) : 2078 - 2100
  • [43] Steroids in inflammatory bowel disease
    San Roman, Antonio Lopez
    Garrido, Elena
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (09) : 573 - 573
  • [44] Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents
    Kemp, Roslyn
    Dunn, Elliott
    Schultz, Michael
    BIODRUGS, 2013, 27 (06) : 585 - 590
  • [45] Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents
    Roslyn Kemp
    Elliott Dunn
    Michael Schultz
    BioDrugs, 2013, 27 : 585 - 590
  • [46] Designing biologic selectivity for inflammatory bowel disease - role of vedolizumab
    Krupka, Niklas
    Baumgart, Daniel C.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 9 : 147 - 154
  • [47] Social media in inflammatory bowel disease: the patient and physician perspective
    Ahmed, Waseem
    Taft, Tiffany H.
    Charabaty, Aline
    CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (04) : 328 - 335
  • [48] INFLAMMATORY BOWEL DISEASE MEETS FERTILITY: A PHYSICIAN AND PATIENT SURVEY
    Vieujean, Sophie
    De Vos, Michel
    D'Amico, Ferdinando
    Paridaens, Kristine
    Daftary, Gaurang S.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    GASTROENTEROLOGY, 2023, 164 (06) : S504 - S504
  • [49] Inflammatory bowel disease meets fertility: A physician and patient survey
    Vieujean, Sophie
    De Vos, Michel
    D'Amico, Ferdinando
    Paridaens, Kristine
    Daftary, Gaurang
    Dudkowiak, Robert
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (07) : 888 - 898
  • [50] Patient Trust-in-Physician and Race Are Predictors of Adherence to Medical Management in Inflammatory Bowel Disease
    Nguyen, Geoffrey C.
    LaVeist, Thomas A.
    Harris, Mary L.
    Datta, Lisa W.
    Bayless, Theodore M.
    Brant, Steven R.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1233 - 1239
12345